Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiming Cai

Showing results (161-170 of 248) with videos related to

Pageof 25
Sort By:
Nature Communications|March 20, 2019
Clonal architectures predict clinical outcome in clear cell renal cell carcinomaYi Huang, Jiayin Wang, Peilin Jia, et al.
Reproduction (Cambridge, England)|October 1, 2013
Decreased expression of cystic fibrosis transmembrane conductance regulator impairs sperm quality in aged menRuiying Diao, Kin Lam Fok, Li Zhao, et al.
Oncotarget|March 26, 2016
shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cellsJianfa Li, Chengle Zhuang, Yuchen Liu, et al.
Oncotarget|May 28, 2016
Artificial small RNA for sequence specific cleavage of target RNA through RNase III endonuclease DicerWen Xu, Yuchen Liu, Yali Liu, et al.
Scientific Reports|November 7, 2015
Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637Yonghao Zhan, Yuchen Liu, Junhao Lin, et al.
Cancer Letters|March 5, 2018
Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cellsHaibiao Xie, Hengji Zhan, Qunjun Gao, et al.
Scientific Reports|September 3, 2016
Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cellsZhicong Chen, Yuchen Liu, Anbang He, et al.
Frontiers in Immunology|June 18, 2026
Prognostic inflammatory-immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter studyZhiming Cai, Zhengnan Xu, Huimei Lin, et al.
Cell Proliferation|December 7, 2018
A revolutionary tool: CRISPR technology plays an important role in construction of intelligentized gene circuitsQun Zhou, Hengji Zhan, Xinhui Liao, et al.
Scientific Reports|September 28, 2023
Author Correction: Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637Yonghao Zhan, Yuchen Liu, Junhao Lin, et al.
Pageof 25

Showing results (161-170 of 248) with videos related to

Sort By:
Pageof 25
Nature Communications|March 20, 2019
Clonal architectures predict clinical outcome in clear cell renal cell carcinomaYi Huang, Jiayin Wang, Peilin Jia, et al.
Reproduction (Cambridge, England)|October 1, 2013
Decreased expression of cystic fibrosis transmembrane conductance regulator impairs sperm quality in aged menRuiying Diao, Kin Lam Fok, Li Zhao, et al.
Oncotarget|March 26, 2016
shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cellsJianfa Li, Chengle Zhuang, Yuchen Liu, et al.
Oncotarget|May 28, 2016
Artificial small RNA for sequence specific cleavage of target RNA through RNase III endonuclease DicerWen Xu, Yuchen Liu, Yali Liu, et al.
Scientific Reports|November 7, 2015
Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637Yonghao Zhan, Yuchen Liu, Junhao Lin, et al.
Cancer Letters|March 5, 2018
Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cellsHaibiao Xie, Hengji Zhan, Qunjun Gao, et al.
Scientific Reports|September 3, 2016
Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cellsZhicong Chen, Yuchen Liu, Anbang He, et al.
Frontiers in Immunology|June 18, 2026
Prognostic inflammatory-immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter studyZhiming Cai, Zhengnan Xu, Huimei Lin, et al.
Cell Proliferation|December 7, 2018
A revolutionary tool: CRISPR technology plays an important role in construction of intelligentized gene circuitsQun Zhou, Hengji Zhan, Xinhui Liao, et al.
Scientific Reports|September 28, 2023
Author Correction: Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637Yonghao Zhan, Yuchen Liu, Junhao Lin, et al.
Pageof 25